# Anaptysbio, Inc: Form 4, filed Apr 22, 2026

- Company: [Anaptysbio, Inc](/companies/anab.md) (CIK 1370053)
- Form: 4
- Filed: 2026-04-22
- Accepted by EDGAR: Apr 22, 2026, 16:05 ET
- Period: 2026-04-20
- Accession: 0001370053-26-000005
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1370053/000137005326000005/xslF345X06/form4-04222026_040403.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1370053/000137005326000005/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1370053/000137005326000005/xslF345X06/form4-04222026_040403.xml

Filed Apr 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001370053-26-000005. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.